CYTORI CELL RESEARCH INSTITUTE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 950 JPY | +0.42% |
|
0.00% | -16.59% |
| Sales 2022 | 1.34B 8.39M 11.44M | Sales 2023 | 2.14B 13.47M 18.37M | Capitalization | 10.12B 63.55M 86.68M |
|---|---|---|---|---|---|
| Net income 2022 | -77M -484K -660K | Net income 2023 | -1.06B -6.65M -9.07M | EV / Sales 2022 | 14.1 x |
| Net Debt 2022 | 8.42B 52.87M 72.12M | Net Debt 2023 | 7.38B 46.38M 63.26M | EV / Sales 2023 | 8.16 x |
| P/E ratio 2022 |
-133
x | P/E ratio 2023 |
-9.55
x | Employees | 64 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 30.4% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.42% | ||
| Current month | -1.86% | ||
| 1 month | -4.04% | ||
| 3 months | -14.41% | ||
| 6 months | -13.71% | ||
| Current year | -16.59% |
1 week
930.00
950.00
1 month
930.00979.00
Current year
881.001 168.00
1 year
730.001 320.00
3 years
730.001 750.00
5 years
408.001 841.00
10 years
160.001 841.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 18-06-19 | |
Toshiyasu Horie
PSD | President | 51 | 17-11-30 |
Hirotaka Todo
BRD | Director/Board Member | 53 | 00-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hirotaka Todo
BRD | Director/Board Member | 53 | 00-08-31 |
Toshiyasu Horie
PSD | President | 51 | 17-11-30 |
Yasushi Sakata
BRD | Director/Board Member | 48 | 13-05-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 950 | +0.42% | 4,300 |
| 24-04-25 | 946 | -0.21% | 8,300 |
| 24-04-24 | 948 | -0.11% | 2,900 |
| 24-04-23 | 949 | -0.11% | 1,600 |
| 24-04-22 | 950 | 0.00% | 2,500 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am
More quotes
Cytori Cell Research Institute Inc is a Japan-based company mainly engaged in the real asset business. The Company operates through two segments. The Real Asset segment is engaged in the purchase and sales of real estate and investment of real estate business related projects, as well as development, renovation and opening of hotels, and operation of hotels. The Medical segment is engaged in the investment of regenerative medicine business centered on cell therapy services, as well as sales of medical equipment and consumables. The main products include Celusion centrifuge and the Celusion cell therapy kit.
Sector
Real Estate Services
Calendar
2024-05-13
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -16.59% | 53.88M | |
| -6.19% | 26.35B | |
| -8.51% | 18.19B | |
| -23.96% | 10.28B | |
| -17.09% | 9.84B | |
| -3.37% | 8.67B | |
| -4.57% | 6.73B | |
| -11.93% | 5.42B | |
| +32.17% | 4.39B | |
| -10.00% | 2.23B |
- Stock Market
- Equities
- 3750 Stock
